Related Experiment Video
Updated: May 29, 2026

Noninvasive, High-throughput Determination of Sleep Duration in Rodents
Published on: April 18, 2018
Follow-up study of cardiac ¹²³I-MIBG scintigraphy in idiopathic REM sleep behavior disorder
T Miyamoto1, M Miyamoto, M Iwanami
1Department of Neurology, Center of Sleep Medicine, Dokkyo Medical University School of Medicine, Tochigi, Japan. sandra.olsson@neuro.gu.se
Background:
Cardiac (123) I-metaiodobenzylguanidine ((123) I-MIBG) uptake in patients with idiopathic rapid eye movement (REM) sleep behavior disorder (iRBD) is markedly reduced, as in Parkinson's disease (PD).
Methods:
We performed (123) I-MIBG scintigrams on patients with iRBD and PD. After the initial (123) I-MIBG scintigram, we retested subjects after a mean of 2.8 years.
Results:
The delayed heart-to-mediastinum (H/M) ratio of cardiac (123) I-MIBG uptake was not significantly reduced between the first and second study in either group (P = 0.050, P = 0.091, respectively). Follow-up imaging revealed a mean decline of 4.21 ± 9.06% or 6.40 ± 19.02% in the delayed H/M ratio in those with iRBD or PD, respectively.
Conclusions:
The (123) I-MIBG uptake findings might indicate progression early in the course of iRBD or PD, but the progression is heterogeneous and independent of development of motor symptoms.
Insights
Cardiac (123) I-metaiodobenzylguanidine ((123) I-MIBG) uptake is reduced in idiopathic REM sleep behavior disorder (iRBD) and Parkinson's disease (PD). Follow-up imaging suggests heterogeneous progression of this cardiac sympathetic denervation in both conditions.
Area of Science:
- Neurology
- Cardiology
- Nuclear Medicine
Background:
- Cardiac (123) I-metaiodobenzylguanidine ((123) I-MIBG) uptake is reduced in idiopathic rapid eye movement (REM) sleep behavior disorder (iRBD), similar to Parkinson's disease (PD).
- This reduction suggests impaired cardiac sympathetic denervation in these neurodegenerative conditions.
Purpose of the Study:
- To evaluate the longitudinal changes in cardiac (123) I-MIBG uptake in patients with iRBD and PD.
- To assess the progression of cardiac sympathetic denervation over time in these patient groups.
Main Methods:
- (123) I-MIBG scintigraphy was performed on patients diagnosed with iRBD and PD.
- Subjects underwent repeat imaging after a mean follow-up period of 2.8 years to assess changes in the heart-to-mediastinum (H/M) ratio.
Main Results:
- The delayed heart-to-mediastinum (H/M) ratio did not show a statistically significant reduction between the initial and follow-up studies in either iRBD or PD groups (P = 0.050 and P = 0.091, respectively).
- A mean decline in the delayed H/M ratio was observed: 4.21 ± 9.06% in iRBD and 6.40 ± 19.02% in PD.
Conclusions:
- Cardiac (123) I-MIBG uptake findings may indicate early progression in iRBD and PD.
- The progression of cardiac sympathetic denervation appears heterogeneous and is independent of motor symptom development.
Related Concept Videos
REM Sleep Behavior Disorder
RBD is significantly associated with...
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET

